Becton, Dickinson and Co logo

Becton, Dickinson and Co - SER B

(Preferred)
NYSE:BDXB.PFD (USA)   PRF PERPETUAL USD 50 - 1/20TH INT Ser B
$ 48.16 +0.66 (+1.39%) 09:42 AM EST
52.53
P/B:
2.69
Volume:
2.76M
Avg Vol (2M):
98.15K
Also Trade In:
Volume:
2.76M
Avg Vol (2M):
98.15K
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for BDXB.PFD ( Becton, Dickinson and Co ) from 2020 to Jun 05 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Becton, Dickinson and stock (BDXB.PFD) PE ratio as of Jun 05 2024 is 52.53. More Details

Becton, Dickinson and Co (BDXB.PFD) PE Ratio (TTM) Chart

To

Becton, Dickinson and Co (BDXB.PFD) PE Ratio (TTM) Historical Data

Total 0
  • 1
Becton, Dickinson and PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data

Becton, Dickinson and Co (BDXB.PFD) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Becton, Dickinson and Co logo
Becton, Dickinson and Co
NAICS : 339112 SIC : 3841
ISIN : US0758874061

Share Class Description:

BDXB.PFD: PRF PERPETUAL USD 50 - 1/20TH INT Ser B
Description
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2023 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.